CDC taps Palantir to support COVID-19 drug supply in U.S.
CDC taps Palantir to support COVID-19 drug supply in U.S.
February 22, 2022; 7:45 AM EST
The logo of U.S. software company Palantir Technologies is seen in Davos, Switzerland January 22, 2020. REUTERS/Arnd Wiegmann
(Reuters) – The Centers for Disease Control and Prevention (CDC) has awarded Palantir Technologies Inc a $5.3 million contract to manage distribution of COVID-19 drugs in the United States, the software maker said on Tuesday.
The contract for supporting distribution of therapeutics is for a duration of six months, Palantir said.
The new partnership is an extension of an existing use of Palantir’s Tiberius platform for vaccine distribution, for which the company was selected in 2020.
Our Standards: The Thomson Reuters Trust Principles.
Reuters source:
